Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Respiratory Distress Syndrome » Respiratory Distress Syndrome, Newborn
Diseases [C] » Respiratory Tract Diseases [C08] » Respiration Disorders » Respiratory Distress Syndrome » Respiratory Distress Syndrome, Newborn
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Infant, Newborn, Diseases » Infant, Premature, Diseases » Respiratory Distress Syndrome, Newborn
Description
A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. MeSH
Hierarchy View
Subtype Terms (2)
Hyaline Membrane Disease
7 drugs (6 approved, 1 experimental)
Transient Tachypnea of the Newborn
8 approved drugs
Approved Indicated Drugs (7)
Phase 4 Indicated Drugs (3)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (6)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (45)
Federal University of Minas Gerais
Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona
Huazhong University of Science and Technology
I.M. Sechenov First Moscow State Medical University
Organization Involved with Phase 3 Indications (155)
Ache Laboratorios Farmaceuticos S.A.
Adolphe Rothschild Ophtalmologic Foundation
Albert Einstein Israelite Hospital
All India Institute of Medical Sciences
Assistance Publique - Hôpitaux de Paris
Blekinge County Council Hospital
Brazilian Research In Intensive Care Network
Canadian Institutes of Health Research (CIHR)
Case Western Reserve University
Centre Chirurgical Marie Lannelongue
Centre Hospitalier de Saint-Brieuc
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Chacha Nehru Bal Chikitsalaya, New Delhi
Demikhov Municipal Clinical Hospital 68
Faculty of Medicine Universitas Indonesia - Dr Cipto Mangunkusumo Hospital
Government Medical College, Chandigarh
Groupe Hospitalier Bretagne Sud
Groupe Hospitalier Diaconesses Croix Saint Simon
Groupe Hospitalier Sud Ile-de-France
Groupe Hospitalier Universitaire Paris psychiatrie & neurosciences
Health Sciences Centre Foundation, Manitoba
Hellenic Institute for the Study of Sepsis
Hospital for Children, Chennai
Icahn School of Medicine at Mount Sinai
Jawaharlal Institute of Postgraduate Medical Education and Research
King Edward Memorial Hospital, Mumbai
Laboratoire français de Fractionnement et de Biotechnologies
Lokmanya Tilak Municipal Medical College
Medical Research Council of Canada
National Center for Research Resources (NCRR)
National Institute of Child Health and Human Development (NICHD)
People's Liberation Army of China
Pneuma Pharmaceuticals Incorporated
Postgraduate Institute of Medical Education and Research
Rajiv Gandhi University of Health Sciences
Shahid Beheshti University of Medical Sciences
The University of Texas, Dallas
University of Alabama, Birmingham
University of British Columbia
University of California, Berkeley
University of California, San Diego
University of California, San Francisco
Organization Involved with Phase 2 Indications (130)
Acute Respiratory Distress Syndrome Foundation
American Society for Parenteral and Enteral Nutrition
A.O. Ospedale Maggiore di Lodi
Autonomous University of Madrid
Cellular Biomedicine Group Ltd.
Claude D. Pepper Older Americans Independence Center
Clinica Universidad de Navarra
European Society for Paediatric Research
Federal University of Rio de Janeiro
Harborview Injury Prevention and Research Center
Hospital Clínica Universitario Virgen de la Arrixaca (SPAIN)
Hospital General Universitario Gregorio Marañon
Hospital of Mantes-la-Jolie, France
Hospital Regional de Alta Especialidad de Zumpango
Institut de Cancerologie Strasbourg Europe
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Ivy Institute of Stem Cells Co. Ltd
Kyoto Prefectural University of Medicine
Methodist Research Institute, Indianapolis
National Polytechnic Institute, Mexico
National Research Center, Egypt
Northern Ireland Clinical Trials Unit
Oregon Health and Science University
Organicell Regenerative Medicine, Inc
Rio de Janeiro Federal University
Rio de Janeiro State University
SP ZOZ Szpital Uniwersytecki w Krakowie Oddizat Neonatologii
Organization Involved with Phase 1 Indications (24)
Organization Involved with Other Experimental Indications (50)
Alta Bates Summit Medical Center
Azienda Ospedaliera San Gerardo di Monza
Catholic University of Sacred Heart, Rome
Centre for Neonatal Research and Education, Crawley, West Australia
Dr. Sami Ulus Children's Hospital
Institute for the Care of Mother and Child, Prague, Czech Republic
Kilimanjaro Christian Medical College, Tanzania
King Edward Medical University
Kliniken der Stadt Koeln, Kinderkrankenhaus Riehl
Klinikum Aschaffenburg-Alzenau
Maple Grove Hospital and North Memorial Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
